Literature DB >> 9294775

Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage.

N Ozbey1, A Oncül, Z Buğra, A Vural, F Erzengin, Y Orhan, K Büyüköztürk, E Sencer, S Molvalilar.   

Abstract

It is recently shown that the majority of acromegalic patients without concomitant heart disease have diastolic dysfunction at rest. The aim of this study is to evaluate left ventricular diastolic function in normotensive acromegalic patients without any evidence of heart disease. Eleven acromegalic patients and 16 normal subjects of comparable age and sex distribution were studied by echocardiography. Left ventricular end-diastolic diameter, interventricular septal thickness, left ventricular posterior wall thickness, left ventricular end-diastolic volume and stroke volume were found to be significantly higher in acromegalic patients. Left ventricular mass and left ventricular mass index increased significantly in acromegalics in comparison with controls (229.16 +/- 46.11 g versus 167.17 +/- 24.57 g and 124.99 +/- 26.91 g/m2 versus 95.09 +/- 13.29 g/m2 respectively, p < 0.001). Mitral A wave desceleration rate and isovolumetric relaxation time (IVRT)-two of the studied parameters of left ventricular diastolic filling- were significantly prolonged in patients as compared with controls (p = 0.03 and p < 0.001 respectively). Four (36%) of the acromegalic patients had peak early/late diastolic mitral velocity ratio lower than 1, indicating diastolic dysfunction. All of the patients had IVRT longer than 90 ms (mean + 2 standart deviations of normals). It is concluded that in acromegalic patients without any other evidence of heart disease left ventricular diastolic function is impaired. This indicates a specific cardiomyopathy exists in the subclinical stage. IVRT is found to be more sensitive than other studied parameters for detecting diastolic dysfunction at this stage.

Entities:  

Mesh:

Year:  1997        PMID: 9294775     DOI: 10.1007/BF03350308

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

Review 1.  Selective insulin action on skin, ovary, and heart in insulin-resistant states.

Authors:  M E Geffner; D W Golde
Journal:  Diabetes Care       Date:  1988-06       Impact factor: 19.112

Review 2.  Diastolic properties of the left ventricle.

Authors:  W Grossman; L P McLaurin
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

3.  Acromegalic cardiopathy: a left ventricular scintigraphic study.

Authors:  N Sicolo; F Bui; M Sicolo; L Varotto; C Martini; C Macor; G Federspil
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

4.  Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study.

Authors:  S Fazio; A Cittadini; D Sabatini; B Merola; A M Colao; B Biondi; G Lombardi; L Saccá
Journal:  Eur Heart J       Date:  1993-01       Impact factor: 29.983

5.  Cardiac size and function in acromegaly.

Authors:  J B Martins; R E Kerber; B M Sherman; M L Marcus; J C Ehrhardt
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

6.  A preliminary study of growth hormone in the treatment of dilated cardiomyopathy.

Authors:  S Fazio; D Sabatini; B Capaldo; C Vigorito; A Giordano; R Guida; F Pardo; B Biondi; L Saccà
Journal:  N Engl J Med       Date:  1996-03-28       Impact factor: 91.245

7.  Impaired left ventricular diastolic filling in patients with acromegaly: assessment with radionuclide angiography.

Authors:  A Cuocolo; E Nicolai; S Fazio; L Pace; S Maurea; A Cittadini; L Saccà; M Salvatore
Journal:  J Nucl Med       Date:  1995-02       Impact factor: 10.057

8.  Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly.

Authors:  B Merola; A Cittadini; A Colao; D Ferone; S Fazio; D Sabatini; B Biondi; L Saccá; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1993-09       Impact factor: 5.958

9.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

10.  Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide.

Authors:  A Giustina; E Boni; G Romanelli; V Grassi; G Giustina
Journal:  Am J Cardiol       Date:  1995-05-15       Impact factor: 2.778

View more
  3 in total

1.  The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly.

Authors:  Laura De Marinis; Antonio Bianchi; Gherardo Mazziotti; Marco Mettimano; Domenico Milardi; Alessandra Fusco; Vincenzo Cimino; Giulio Maira; Alfredo Pontecorvi; Andrea Giustina
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  Left ventricular diastolic function abnormalities in hypopituitary patients with GH deficiency: evidence for a subclinical cardiomyopathy.

Authors:  N Ozbey; A Sezgil; H Oflaz; B Umman; Y Orhan; E Sencer; S Molvalilar
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

3.  Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience.

Authors:  Pinaki Dutta; Bhuvanesh Mahendran; K S Reddy; Jasmina Ahluwalia; Kim Vaiphei; R K Kochhar; Prakamya Gupta; Anand Srinivasan; Mahesh Prakash; Kanchan Kumar Mukherjee; V N Shah; Girish Parthan; Anil Bhansali
Journal:  Endocr Connect       Date:  2015-01-19       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.